Unknown

Dataset Information

0

[Studies and Progress of EGFR exon 20 Insertion Mutation in Non-small Cell Lung Cancer].


ABSTRACT: Lung cancer has the highest morbidity and mortality among malignant tumors worldwidely. Targeted therapy related to non-small cell lung cancer (NSCLC) is the research hotspot in recent year. The emergence of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) has brought a huge change in the treatment of patients with EGFR mutation. The patients with EGFR exon20 insertion are specific cohort in NSCLC. Reviewing the clinical researches to EGFR exon20 insertion mutation positive NSCLC, as well as summarizing character, testing methods and treatment, will provide a help for clinical application, bringing more benefits for patients at the same time.

SUBMITTER: Zhou W 

PROVIDER: S-EPMC7049789 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5596996 | BioStudies
2019-01-01 | S-EPMC6473281 | BioStudies
2019-01-01 | S-EPMC6405763 | BioStudies
2018-01-01 | S-EPMC6118895 | BioStudies
2013-01-01 | S-EPMC3954775 | BioStudies
2019-01-01 | S-EPMC6806250 | BioStudies
1000-01-01 | S-EPMC5762318 | BioStudies
2018-01-01 | S-EPMC5999922 | BioStudies
1000-01-01 | S-EPMC5095551 | BioStudies
2019-01-01 | S-EPMC6935036 | BioStudies